NCT05765344 - Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

January 13, 2025

Study Completion Date

January 13, 2025

Conditions

Chronic Hepatitis D Infection

Interventions

DRUG

Bulevirtide

Administered via subcutaneous injections.

Trial Locations (6)

Orlando Clinical Research Center, Orlando

Clinical Pharmacology of Miami, LLC, Miami

University of Miami, Miami

Texas Liver Institute, San Antonio

Pinnacle Clinical Research LLC, San Antonio

Orange County Research Center, Lake Forest